Drug
Fk506e
Fk506e: highest development phase Phase 3, developed by Astellas. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Astellas
Trials
| Drug | Phase | Indication |
|---|---|---|
| FK506E (modified release tacrolimus) NCT00909571 | Phase 3 | Liver Transplantation |
Latest
No recent events.
Follow Fk506e on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.